×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

A 14-Day version of Libre Continuous Glucose Monitor approved

  1112 Views

eMediNexus    29 July 2018

The US Food and Drug Administration (FDA) has approved Abbotts Freestyle Libre 14-Day Flash Glucose Monitoring System, to replace the current 10-day version, which had been approved by the FDA in September 2017. It is currently approved for adults aged 18 years and older by prescription.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.